THE SINGLE BEST STRATEGY TO USE FOR UPROSERTIB

Pharmacological inhibition of the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; often known as FRAP-associated protein (FRP1)) has emerged as a promising approach for most cancers cure that exploits synthetic lethal interactions with proteins involved with DNA problems repair, overcomes resistance to other therapies an